药明合联早盘涨逾10% 宣布与AbTis签署战略合作意向书

新浪网
14 Mar

药明合联早盘上涨9.70%,现报38.45港元,成交额1.05亿港元。3月11日,药明合联宣布与韩国生物技术公司AbTis签署战略合作意向书(MOU)。根据协议,药明合联将纳入AbTis的先进定点偶联技术平台AbClick。该技术平台通过亲和肽辅助,实现精准高效的抗体-药物偶联。药明合联将依托其广泛的全球客户网络,全力推动AbTis技术的广泛应用,助力双方在生物偶联药领域的深度合作与共赢。此次合作...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10